Berotralstat HCl is a selective plasma kallikrein inhibitor that prevents bradykinin generation, the key mediator of swelling in hereditary angioedema (HAE). It is used in biochemical research to study kallikrein-kinin system pharmacology and has been evaluated in both in vitro enzymatic assays and in vivo preclinical models of HAE.
Molekulargewicht:
635.4886
CAS Nummer:
[1809010-52-3]
Formel:
C30H28Cl2F4N6O
Target-Kategorie:
Others,Serine Protease
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten